Loading company details...
Beta
Latest Form 4 (Jul 31, 2026): Warren Nighan Jr. (SVP Quality and Regulatory): Sale of 23,370 shares, $344.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 31, 2026 | Warren Nighan Jr., SVP Quality and Regulatory | Sale | 23,370 | $344.0K |
| Jul 24, 2026 | Laura Piccinini, SVP International | Exercise/Conversion | 8,047 | n/a |
| Jul 24, 2026 | Warren Nighan Jr., SVP Quality and Regulatory | Exercise/Conversion | 5,694 | n/a |
| Jul 24, 2026 | Stephen A. Trowbridge, EVP and CFO | Exercise/Conversion | 16,296 | n/a |
| Jul 24, 2026 | James C. Clemmer, President and CEO | Exercise/Conversion | 52,358 | n/a |
| Jul 24, 2026 | Chad Thomas Campbell, SVP/GM, Vascular Access | Exercise/Conversion | 6,466 | n/a |
| Jul 23, 2026 | Jan Stern Reed | Grant/Award | 11,887 | n/a |
| Jul 23, 2026 | Karen A. Licitra | Grant/Award | 11,887 | n/a |
| Jul 23, 2026 | Wesley Johnson | Grant/Award | 11,887 | n/a |
| Jul 23, 2026 | Howard W. Donnelly | Grant/Award | 11,887 | n/a |